COMMUNIQUÉS West-GlobeNewswire

-
Stemline In-Licenses Worldwide Rights to Novel Selective RET Inhibitor (SL-1001); Expands Oncology Pipeline
11/03/2019 -
Aclaris Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results on March 18, 2019
08/03/2019 -
UPDATE - electroCore Appointments Multiple Industry Veterans to Key Management Positions
08/03/2019 -
Sanofi: Filing of the 2018 U.S. Form 20-F and French « Document de Référence » containing the Annual Financial Report
08/03/2019 -
Sanofi : Dépôt du Document de Référence 2018, contenant le Rapport Financier Annuel, et du « Form 20-F » américain
08/03/2019 -
LeMaitre Vascular to Present at Upcoming Investor Conferences
08/03/2019 -
Audited Financial Statements' Announcement for The Year Ended 31 December 2018
08/03/2019 -
Emblem Receives Final Order Approving Arrangement With Aleafia
08/03/2019 -
Exactus Announces Stock Split
08/03/2019 -
Nextech and Relatient Announce Partnership to Enhance Patient Experience and Practice Revenue
08/03/2019 -
Intrommune Therapeutics Announces Grant of European Patent Covering Oral Mucosal Immunotherapy for Food Allergy
08/03/2019 -
Allovate Therapeutics Announces Grant of European Patent Covering Oral Mucosal Immunotherapy Platform
08/03/2019 -
Tabula Rasa HealthCare to Participate in Upcoming Investor Conference
08/03/2019 -
Altimmune Announces $14 million Registered Direct Offering
08/03/2019 -
Alphatec Announces Participation At Canaccord and Cowen Investor Conferences in March
08/03/2019 -
Y-mAbs Therapeutics To Present At Cowen’s 39th Annual Health Care Conference
08/03/2019 -
Generex Biotechnology Subsidiary Olaregen Therapeutix Announces the Appointment of Vice President of Business Strategy
08/03/2019 -
Cronos Group Inc. Closes C$2.4 Billion Strategic Growth Investment from Altria Group, Inc.
08/03/2019 -
Kaleido Biosciences to Highlight its Platform to Identify and Evaluate Microbiome Metabolic Therapies to Reduce Gut Ammonia Production in Presentation at Keystone Symposia on Microbiome
08/03/2019
Pages